Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 4 of 4 items for :

  • macimorelin x
Clear All
Jose M Garcia GRECC VA Puget Sound HCS/University of Washington, Seattle, Washington, USA

Search for other papers by Jose M Garcia in
Google Scholar
PubMed Close
,
Beverly M K Biller Massachusetts General Hospital, Neuroendocrine Unit, Boston, Massachusetts, USA

Search for other papers by Beverly M K Biller in
Google Scholar
PubMed Close
,
Márta Korbonits Barts and the London School of Medicine, Queen Mary University of London, Endocrinology, London, UK

Search for other papers by Márta Korbonits in
Google Scholar
PubMed Close
,
Vera Popovic University of Belgrade, Medical Faculty, Belgrade, Serbia

Search for other papers by Vera Popovic in
Google Scholar
PubMed Close
,
Anton Luger Division of Endocrinology and Metabolism, Medical University, General Hospital, Vienna, Austria

Search for other papers by Anton Luger in
Google Scholar
PubMed Close
,
Christian J Strasburger Charité-Universitätsmedizin, Clinical Endocrinology CCM, Berlin, Germany

Search for other papers by Christian J Strasburger in
Google Scholar
PubMed Close
,
Philippe Chanson Assistance Publique-Hôpitaux de Paris, Hôpital de Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, and Université Paris-Saclay, Univ. Paris-Sud, Inserm, Signalisation Hormonale, Physiopathologie Endocrinienne et Métabolique, Le Kremlin-Bicêtre, France

Search for other papers by Philippe Chanson in
Google Scholar
PubMed Close
,
Ronald Swerdloff The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA

Search for other papers by Ronald Swerdloff in
Google Scholar
PubMed Close
,
Christina Wang The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA

Search for other papers by Christina Wang in
Google Scholar
PubMed Close
,
Rosa Rosanna Fleming Strongbridge Biopharma, Trevose, Pennsylvania, USA

Search for other papers by Rosa Rosanna Fleming in
Google Scholar
PubMed Close
,
Fredric Cohen Strongbridge Biopharma, Trevose, Pennsylvania, USA

Search for other papers by Fredric Cohen in
Google Scholar
PubMed Close
,
Nicola Ammer Aeterna Zentaris GmbH, Frankfurt, Hessen, Germany

Search for other papers by Nicola Ammer in
Google Scholar
PubMed Close
,
Gilbert Mueller Aeterna Zentaris GmbH, Frankfurt, Hessen, Germany

Search for other papers by Gilbert Mueller in
Google Scholar
PubMed Close
,
Nicky Kelepouris Novo Nordisk Inc., Plainsboro, New Jersey, USA

Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed Close
,
Frank Strobl Novo Nordisk Inc., Plainsboro, New Jersey, USA

Search for other papers by Frank Strobl in
Google Scholar
PubMed Close
,
Vlady Ostrow Novo Nordisk Inc., Plainsboro, New Jersey, USA

Search for other papers by Vlady Ostrow in
Google Scholar
PubMed Close
, and
Kevin C J Yuen University of Arizona College of Medicine and Creighton School of Medicine, Barrow Pituitary Center, Barrow Neurological Institute, Phoenix, Arizona, USA

Search for other papers by Kevin C J Yuen in
Google Scholar
PubMed Close

effects, including nausea, vomiting, and headache ( 19 ). Macimorelin is an orally active ghrelin receptor agonist that is indicated for the diagnosis of AGHD in the United States ( 26 ) and Europe ( 27 ). Macimorelin is well-tolerated; the most frequent

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-20-0491
Volume/Issue:
Volume 10: Issue 1
Open access
Kevin C J Yuen Departments of Neuroendocrinology and Neurosurgery, Barrow Neurological Institute, University of Arizona College of Medicine and Creighton School of Medicine, Phoenix, Arizona, United States

Search for other papers by Kevin C J Yuen in
Google Scholar
PubMed Close
,
Gudmundur Johannsson Department of Endocrinology, Sahlgrenska University Hospital and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed Close
,
Ken K Y Ho The Garvan Institute of Medical Research and the Faculty of Medicine, University of New South Wales, Sydney, Australia

Search for other papers by Ken K Y Ho in
Google Scholar
PubMed Close
,
Bradley S Miller Pediatric Endocrinology, University of Minnesota Medical School, M Health Fairview Masonic Children’s Hospital, Minneapolis, Minnesota, United States

Search for other papers by Bradley S Miller in
Google Scholar
PubMed Close
,
Ignacio Bergada Centro de Investigaciones Endocrinológicas "Dr César Bergadá" (CEDIE), CONICET-FEI-División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina

Search for other papers by Ignacio Bergada in
Google Scholar
PubMed Close
, and
Alan D Rogol Pediatric Diabetes and Endocrinology, University of Virginia, Charlottesville, Virginia, United States

Search for other papers by Alan D Rogol in
Google Scholar
PubMed Close

discriminate with acceptable sensitivity and specificity between healthy children ( 66 ) and GH-deficient patients and limited accessibility (only accessible in Japan) ( 72 ) Macimorelin ≤2.8 First oral GH secretagogue to be approved as a diagnostic

Article Type:
Review Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-22-0504
Volume/Issue:
Volume 12: Issue 7
Open access
Jelena Stankovic Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Jelena Stankovic in
Google Scholar
PubMed Close
,
Kurt Kristensen Steno Diabetes Center Aarhus (SDCA), Aarhus University Hospital, Aarhus, Denmark
Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Kurt Kristensen in
Google Scholar
PubMed Close
,
Niels Birkebæk Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Niels Birkebæk in
Google Scholar
PubMed Close
,
Jens Otto Lunde Jørgensen Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Jens Otto Lunde Jørgensen in
Google Scholar
PubMed Close
, and
Esben Søndergaard Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Steno Diabetes Center Aarhus (SDCA), Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Esben Søndergaard in
Google Scholar
PubMed Close

challenging ( 9 ). Glucagon has also been shown to stimulate copeptin secretion, whereas the ghrelin-receptor agonist, macimorelin, has failed to stimulate copeptin ( 10 ). Arginine infused intravenously is assumed to suppress hypothalamic somatostatin

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-23-0042
Volume/Issue:
Volume 12: Issue 11
Open access
M Guftar Shaikh Department of Paediatric Endocrinology, Royal Hospital for Children, Glasgow, UK
Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK

Search for other papers by M Guftar Shaikh in
Google Scholar
PubMed Close
,
Timothy G Barrett Department of Endocrinology, Birmingham Womens and Children’s Hospital, Birmingham, UK
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

Search for other papers by Timothy G Barrett in
Google Scholar
PubMed Close
,
Nicola Bridges Department of Paediatric Endocrinology, Chelsea and Westminster Hospital, London, UK

Search for other papers by Nicola Bridges in
Google Scholar
PubMed Close
,
Robin Chung Research Working Group, Prader-Willi Syndrome Association, Northampton, UK

Search for other papers by Robin Chung in
Google Scholar
PubMed Close
,
Evelien F Gevers Department of Paediatric Endocrinology, Barts Health NHS Trust, Royal London Hospital, London, UK
Centre for Endocrinology, William Harvey Research Institute, Barts and The London Medical School, Queen Mary University of London, London, UK

Search for other papers by Evelien F Gevers in
Google Scholar
PubMed Close
,
Anthony P Goldstone PsychoNeuroEndocrinologyResearch Group, Division of Psychiatry, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK

Search for other papers by Anthony P Goldstone in
Google Scholar
PubMed Close
,
Anthony Holland Department of Psychiatry, University of Cambridge, Cambridge, UK

Search for other papers by Anthony Holland in
Google Scholar
PubMed Close
,
Shankar Kanumakala Royal Alexandra Children’s Hospital, Brighton, UK

Search for other papers by Shankar Kanumakala in
Google Scholar
PubMed Close
,
Ruth Krone Department of Endocrinology, Birmingham Womens and Children’s Hospital, Birmingham, UK

Search for other papers by Ruth Krone in
Google Scholar
PubMed Close
,
Andreas Kyriakou Department of Paediatric Endocrinology, Royal Hospital for Children, Glasgow, UK
Department of Paediatric Endocrinology, Makarios Children's Hospital, Nicosia, Cyprus

Search for other papers by Andreas Kyriakou in
Google Scholar
PubMed Close
,
E Anne Livesey Royal Alexandra Children’s Hospital, Brighton, UK
Sussex Community NHS Trust, Brighton, UK

Search for other papers by E Anne Livesey in
Google Scholar
PubMed Close
,
Angela K Lucas-Herald Department of Paediatric Endocrinology, Royal Hospital for Children, Glasgow, UK
Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK

Search for other papers by Angela K Lucas-Herald in
Google Scholar
PubMed Close
,
Christina Meade CHI at Tallaght University Hospital, Dublin, Republic of Ireland

Search for other papers by Christina Meade in
Google Scholar
PubMed Close
,
Susan Passmore Prader-Willi Syndrome Association, Northampton, UK

Search for other papers by Susan Passmore in
Google Scholar
PubMed Close
,
Edna Roche CHI at Tallaght University Hospital, Dublin, Republic of Ireland
The University of Dublin, Trinity College Dublin, Dublin, Republic of Ireland

Search for other papers by Edna Roche in
Google Scholar
PubMed Close
,
Chris Smith Royal Alexandra Children’s Hospital, Brighton, UK

Search for other papers by Chris Smith in
Google Scholar
PubMed Close
, and
Sarita Soni Learning Disability Psychiatry, NHS Greater Glasgow and Clyde, Glasgow, UK

Search for other papers by Sarita Soni in
Google Scholar
PubMed Close

issues with GHRH, however, an oral macimorelin (growth hormone secretagogue) test could be considered, although this has not been studied in patients with PWS to date. If GHD is confirmed, adult GH replacement therapy as per current UK NICE guidance can

Article Type:
Other
Collections:
Obesity
DOI:
https://doi.org/10.1530/EC-24-0091
Volume/Issue:
Volume 13: Issue 8
Open access